Internal Medicine · Columbia, SC
NPI
1649431990
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
166 Stoneridge Dr
Columbia, SC, 29210
Phone (803) 461-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.7M
321,984 services
Medicare patients, 2024
1,340
Average age 75
Drug cost, 2024
$3.0M
1,638 prescriptions
Company payments, 2025
$2,254
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Minter was code J1439 (injection, ferric carboxymaltose, 1 mg), 70,500 times for 53 patients. In total Steven Minter billed 321,984 services in 206 codes, and Medicare paid $4.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 70,500 | 53 | $0.85 | $60K |
| J0897 Injection, denosumab, 1 mg | Office | 23,460 | 108 | $20.28 | $476K |
| J0185 Injection, aprepitant, 1 mg | Office | 23,010 | 47 | $1.34 | $31K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 20,585 | 152 | $0.10 | $2,070 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 17,900 | 16 | $0.06 | $1,011 |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 15,000 | 44 | $4.40 | $66K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,400 | 21 | $44.60 | $464K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 8,460 | 14 | $39.19 | $332K |
| A9585 Injection, gadobutrol, 0.1 ml | Office | 6,980 | 51 | $0.24 | $1,698 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 6,336 | 28 | $20.61 | $131K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,887 | 12 | $0.08 | $467 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,840 | 88 | $0.09 | $340 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 3,340 | 11 | $35.42 | $118K |
| 36415 Venipuncture Blood Collection | Office | 3,020 | 800 | $8.60 | $26K |
| 85025 Blood Count | Office | 2,851 | 782 | $7.60 | $22K |
By year: 2022 $4.6M for 296,084 services; 2023 $4.0M for 262,226 services; 2024 $4.7M for 321,984 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 3,020 | 800 | $8.60 | $26K |
| 85025 Blood Count | 2,851 | 782 | $7.60 | $22K |
| 80048 Clinical Chemistry | 2,684 | 769 | $8.28 | $22K |
| 80076 Clinical Chemistry | 2,648 | 768 | $8.00 | $21K |
| 82784 Immunoassay | 635 | 90 | $9.00 | $5,718 |
| 82728 Clinical Chemistry | 323 | 182 | $13.19 | $4,262 |
| 85044 Blood Count | 319 | 185 | $4.21 | $1,342 |
| 83550 Clinical Chemistry | 307 | 177 | $8.46 | $2,597 |
| 83540 Clinical Chemistry | 307 | 177 | $6.26 | $1,921 |
| 83615 Clinical Chemistry | 219 | 151 | $5.92 | $1,296 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven Minter prescribed most often to Medicare patients was Letrozole, with 306 prescriptions and refills. In total Steven Minter wrote 1,638 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 306 | 678 | 89 | $6,369 |
| Acyclovir Generic | 101 | 129 | 26 | $1,210 |
| Dexamethasone Generic | 86 | 97 | 30 | $1,142 |
| Eliquis Apixaban | 72 | 104 | 23 | $60K |
| Hydroxyurea Generic | 64 | 117 | 16 | $959 |
| Tamoxifen Citrate Generic | 62 | 168 | 25 | $1,691 |
| Ondansetron Odt Ondansetron | 58 | 59 | 51 | $1,181 |
| Anastrozole Generic | 56 | 116 | 19 | $1,490 |
| Revlimid Lenalidomide | 41 | 41 | 18 | $694K |
| Prednisone Generic | 37 | 41 | 21 | $139 |
| Imatinib Mesylate Generic | 37 | 43 | Under 11 | $51K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | 20 | $619 |
| Potassium Chloride Generic | 33 | 41 | 16 | $671 |
| Promethazine Hcl Generic | 32 | 32 | 19 | $223 |
| Gabapentin Generic | 28 | 32 | Under 11 | $166 |
Brand drugs: - claims; generic drugs: 1,353 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Minter $2,254 ($2,254 in general payments such as food, travel and fees) from 16 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,556.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 26 | $1,556 |
| Celgene Corporation BMY | 7 | $135 |
| Pfizer Inc. PFE | 4 | $87.39 |
| Janssen Biotech, Inc. JNJ | 4 | $82.25 |
| Array Biopharma Inc PFE | 4 | $61.4 |
| Abbvie Inc. ABBV | 2 | $60.03 |
| Gilead Sciences, Inc. GILD | 2 | $50.1 |
| Adc Therapeutics America, Inc. | 2 | $40.31 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $34.67 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $30.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.